High-Density Lipoproteins and Apolipoprotein A1.

Area of Science:

• Cardiovascular Biology
• Lipid Metabolism
• Molecular Medicine

Background:

• High-density lipoprotein (HDL) and its primary protein, apolipoprotein A-I (apoA-I), are central to cholesterol homeostasis.
• HDLs are a heterogeneous particle group with varied sizes and compositions.
• HDL's primary role is reverse cholesterol transport, moving cholesterol from periphery to the liver for excretion.

Purpose of the Study:

• To discuss the general features, synthesis, and metabolism of apoA-I and HDLs.
• To provide an overview of HDL functions, including antioxidant, anti-inflammatory, and anti-thrombotic effects.
• To examine HDL's role in major pathologies and its therapeutic potential.

Main Methods:

• Literature review and synthesis of existing research on HDL and apoA-I.
• Discussion of biochemical and physiological aspects of HDL metabolism.
• Analysis of HDL's involvement in cardiovascular disease, cancer, and diabetes.

Main Results:

• HDL particles are heterogeneous, with apoA-I being a key component.
• Beyond reverse cholesterol transport, HDL exhibits significant anti-oxidant, anti-inflammatory, and anti-thrombotic properties.
• HDL dysfunction is implicated in cardiovascular disease, cancer, and diabetes.

Conclusions:

• ApoA-I and HDL possess multifaceted functions critical for maintaining health.
• Understanding HDL's complex roles is essential for developing effective therapeutic strategies.
• Future research holds promise for harnessing HDL's potential in treating major diseases.